This story was originally published by ProPublica. Sharelle Menard once believed her son Benji would never be able to speak. Unable to comfort him, read to him, or take him out in public, she felt helpless. However, after a diagnosis of severe autism and specialized therapy, Benji began to make progress. His first word, “bubbles,” filled Menard with hope for his future. But now, their insurer, UnitedHealthcare, is denying Benji the necessary hours of therapy he needs to continue his development. This decision is part of a cost-cutting campaign within the company, targeting the increasing financial burden of treating children with autism. Despite recognizing the effectiveness of the therapy Benji needs, the company is taking steps to limit children’s access to it in order to save money. This strategy impacts children covered by the company’s state-contracted Medicaid plans, potentially forcing families to find new providers or pay out-of-pocket for essential care. Mental health and autism experts have condemned this approach, calling it unethical and harmful to vulnerable patients. Despite criticism and legal concerns, UnitedHealthcare continues to restrict access to therapy for children like Benji, jeopardizing their progress and well-being.
